NCT00569062 - A Study of GW856553X For the Treatment of Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 12, 2007

Primary Completion Date

June 25, 2008

Study Completion Date

June 25, 2008

Conditions

Depressive Disorder, Major

Interventions

DRUG

GW856553X

GW856553X 7.5mg BID for 6 weeks

OTHER

Placebo

Placebo to match GW856553X

Trial Locations (15)

50417

GSK Investigational Site, Tartu

107076

GSK Investigational Site, Moscow

115522

GSK Investigational Site, Moscow

119992

GSK Investigational Site, Moscow

123367

GSK Investigational Site, Moscow

141001

GSK Investigational Site, Ludhiana

193167

GSK Investigational Site, Saint Petersburg

400010

GSK Investigational Site, Mumbai

411004

GSK Investigational Site, Pune

560029

GSK Investigational Site, Bangalore

560034

GSK Investigational Site, Bangalore

603115

GSK Investigational Site, Nizhny Novgorod

576 104

GSK Investigational Site, Manipal

Unknown

GSK Investigational Site, Saint Petersburg

214 019

GSK Investigational Site, Smolensk